Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by StockNews.com
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a note issued to investors on Monday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Shares of BTX stock opened at $5.59 on Monday. The stock has a 50 day moving average price of $4.43 and […]
